Pluri Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Pluri Inc. (PLUR) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $3.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-09-10
- Pluri Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-30 was -$2.00K.
- Pluri Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was -$10.00K, a 105.78% decline year-over-year.
- Pluri Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-06-30 was -$124.00K.
- Pluri Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-03-31 was $173.00K.
- Pluri Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2026 was $3.00K, a 96.67% decline from fiscal 2025.
- Pluri Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $90.00K, a 2150.00% increase from fiscal 2024.
- Pluri Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $4.00K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | -$12.00K derived: sum of 2 quarters · filed 2026-09-10 | $3.00K 10-K · filed 2026-09-10 | |
| 2026-03-31 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | $5.00K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $15.00K 10-Q · filed 2026-02-12 | |||
| 2025-06-30 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $49.00K derived: sum of 2 quarters · filed 2026-09-10 | $71.00K derived: sum of 3 quarters · filed 2026-09-10 | $90.00K 10-K · filed 2026-09-10 |
| 2025-03-31 | $173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | $195.00K derived: sum of 2 quarters · filed 2026-05-14 | $214.00K 10-Q · filed 2026-05-14 | $184.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | $41.00K 10-Q · filed 2026-02-12 | $11.00K derived: sum of 3 quarters · filed 2026-02-12 | -$35.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $19.00K 10-Q · filed 2025-11-12 | -$11.00K derived: sum of 2 quarters · filed 2025-11-12 | -$57.00K derived: sum of 3 quarters · filed 2025-11-12 | -$95.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | -$76.00K derived: sum of 2 quarters · filed 2025-09-17 | -$114.00K derived: sum of 3 quarters · filed 2025-09-17 | $4.00K 10-K · filed 2025-09-17 |
| 2024-03-31 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$84.00K derived: sum of 2 quarters · filed 2025-05-13 | $34.00K 10-Q · filed 2025-05-13 | |
| 2023-12-31 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | $80.00K 10-Q · filed 2025-02-11 | ||
| 2023-09-30 | $118.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |